Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1994
05/26/1994CA2148582A1 Therapeutic agents
05/26/1994CA2148473A1 Xanthine derivatives for use as diuretics
05/26/1994CA2148220A1 Method for producing composition for solid medicine
05/26/1994CA2147859A1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
05/26/1994CA2147503A1 Substituted dipeptide analogs promote release of growth hormone
05/26/1994CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
05/26/1994CA2109900A1 Heterocyclic compounds with antiasthmatic/anti-allergic, anti-inflammatory, positive inotropic and blood pressure-reducing effect
05/25/1994EP0598702A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same
05/25/1994EP0598474A1 2-Deoxy-2-amino hexuronyl derivatives of heparin and a method for production
05/25/1994EP0598375A2 5-Thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo analogs of beta-lactam, processesfor the preparation thereof and the use thereof
05/25/1994EP0598365A1 Agent for the treatment of an atopic eczema and other inflammatory skin diseases
05/25/1994EP0598359A1 Hypoglycemic dihydrochalcone derivatives
05/25/1994EP0598171A1 Nitrogen bridge tetrahydroisoquinolines
05/25/1994EP0598123A1 Piperazine derivative and drug containing the same
05/25/1994EP0598093A1 Quinuclidine derivatives as squalene synthetase inhibitors
05/25/1994EP0598089A1 Novel fluorinated quinolones, process for their preparation and pharmaceutical preparations containing same
05/25/1994EP0598061A1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
05/25/1994EP0598046A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
05/25/1994EP0597968A1 New leukotriene-b 4? antagonists, methods of preparing them and their use as drugs
05/25/1994EP0597966A1 Cns active tetrahydrobenzothienopyridines
05/25/1994EP0597956A1 Quinazoline derivatives as acetylcholinesterase inhibitors
05/25/1994EP0597915A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
05/25/1994EP0597903A1 Mixtures with an antimicrobial action
05/25/1994EP0597833A1 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
05/25/1994EP0597831A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
05/25/1994EP0597830A1 Use of polyamines as ionic-channel regulating agents
05/25/1994EP0566638A4 Flavor stable zinc acetate compositions for oral absorption
05/25/1994EP0559768B1 Oral spiramycine formulations and method for preparing same
05/25/1994EP0455808B1 New use of gamma butyrobetaine for preventing diet induced carnitine deficiency in domesticated dogs and cats
05/25/1994EP0434833B1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use
05/25/1994EP0358660B1 Synthetic inhibitors of mammalian collagenase
05/25/1994EP0357793B1 Suspended-release preparation prepared by using alginates
05/25/1994CN1087092A New 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors
05/25/1994CN1087090A Complete synthesizing process for compound of 17-substituted 11 beta-substituted aromatic base 4,9-estradiene
05/25/1994CN1087089A Therapeutic nucleosides
05/25/1994CN1087088A Ni-substituted 1H-1,2,3-triazdo|4,5-d¨ pyrimidine, preparing of same and application as antivirus pharmaceutical
05/25/1994CN1087086A Thiazolylvinylphenyl derivatives
05/25/1994CN1087085A Pesticidal compounds
05/25/1994CN1087084A New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloa lkylacetamides
05/25/1994CN1087083A Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
05/25/1994CN1087080A Benzenealkanoic acids for cardiovascular diseases
05/25/1994CN1087079A (-)-Ritodrine
05/25/1994CN1087015A Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin
05/25/1994CN1087013A Capsule for treating hepatitis
05/25/1994CN1087011A "Weikang" capsule for treating gastric ulcer and preparing process thereof
05/25/1994CN1087000A Compound stomach medicine for treating gastric ulcer
05/25/1994CN1086999A External-use oinment for treating commonly encountered skin diseases
05/25/1994CN1086998A Pharmaceutical compositions for oral use and method of preparing them
05/25/1994CN1086997A A method of vasodilator therapy
05/25/1994CN1024669C Cephem compound and process for preparation thereof
05/25/1994CN1024668C Process for preparing 2-(2-isoxazolyl)-2-tetrahydrofuran carboxylic acid derivatives
05/25/1994CN1024667C Process for preparing substituted aminomethytetralins and their heterocyclic analogues
05/25/1994CN1024665C Ring-substituted 2-amino-1,2,3-tetrahydronaphthalenes and its producing process
05/25/1994CN1024663C Process for preparing substituted tetralins and related compounds in treatment of asthma
05/25/1994CN1024626C Process for preparing tetrahydrobenz |c,d¨ indole serotonin agonists
05/25/1994CA2109774A1 Pyrrole derivatives, preparation and therapeutical use thereof
05/25/1994CA2109644A1 Agent and method for the immunological determination of amiodarone and its metabolites
05/25/1994CA2109636A1 Process for preparing immunoconjugates
05/24/1994USRE34618 Solution with polyhydric alcohol; storage stability
05/24/1994USRE34617 An edible, nonabsorbable, indigestible liquid sugar esterified by a fatty acid, a diarrhea prevention agent and fat-soluble vitamins; anticholesterol and lipemic agents; cooking shortenings
05/24/1994US5315019 Continuous process for the manufacture of 2,5-dihydrofurans from γ, δ-epoxybutenes
05/24/1994US5315017 Peroxidation and eicosanoid biosynthesis inhibition
05/24/1994US5315012 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds
05/24/1994US5314999 Fungicides, amphoteracin derivatives
05/24/1994US5314919 Calcium malate-citrate
05/24/1994US5314918 Leukotriene antagonists
05/24/1994US5314917 Method for inactivating enveloped viruses and sperm
05/24/1994US5314914 Methods and compositions for combatting herpes viruses
05/24/1994US5314911 Antitumor, fungicide
05/24/1994US5314909 Use of non-steroidal antiiflammatory agents in macular degeneration
05/24/1994US5314908 Compounds useful as antiproliferative agents
05/24/1994US5314907 3-aminochroan compounds
05/24/1994US5314906 Derivatives of physostigmine, their use and pharmaceutical formulations containing them
05/24/1994US5314905 Antitumor
05/24/1994US5314904 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
05/24/1994US5314903 Benzimidazole compounds useful as calcium channel blockers
05/24/1994US5314901 1,2,5,6-tetrahydropyridine oxime compounds
05/24/1994US5314899 Epibatidine and derivatives, compositions and methods of treating pain
05/24/1994US5314896 Dopaminergic agents, antipsychotic and hypotensive agents
05/24/1994US5314895 Benzopyran class III antiarrhythmic agents
05/24/1994US5314894 Pure enantiomer
05/24/1994US5314893 Antiviral tetrahydropyrans
05/24/1994US5314891 Lipoxygenase inhibitors
05/24/1994US5314890 Treatment of asthma
05/24/1994US5314889 Hormone antagonists
05/24/1994US5314888 Veterinary method for treating inappropriate elimination of urine in household pets
05/24/1994US5314886 N-substituted lactams useful as cholecystokinin antagonists
05/24/1994US5314885 Psychological disorders, anticonvulsants
05/24/1994US5314884 2-pyrimidinyl-1-piperazine derivatives processes for their preparation and medicaments containing them
05/24/1994US5314883 Vasodilation, anticoagulants
05/24/1994US5314882 Method for promoting growth and improved meat quality in meat producing animals with female steroidal hormones
05/24/1994US5314881 Wound healing
05/24/1994US5314880 Benzimidazole derivatives
05/24/1994US5314878 Composition for removing or inactivating harmful components in blood or other extracellular body fluids
05/24/1994US5314877 Cariostatic
05/24/1994US5314876 High molecular mass N,O-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them
05/24/1994US5314872 Glucan sulfate, stabilized fibroblast growth factor composition
05/24/1994US5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
05/24/1994US5314694 Transdermal formulations, methods and devices
05/24/1994US5314689 Acyl-carnitine for the treatment and prevention of viral infections